Fritz Christian Eilber

17PUBLICATIONS
57CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Nutrigenomics and personalised nutritionApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Radiation therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Jul 31, 2026
PPARG governs adipogenic differentiation and cell state plasticity in well-differentiated and dedifferentiated liposarcoma.

|Mar 05, 2026
Neoadjuvant BO-112 and Hypofractionated Radiation Therapy with or without Nivolumab in Soft-Tissue Sarcoma: Preclinical and Phase I Results.

Jie Deng, Aastha Pal, Stefano Testa

|Sep 14, 2024
Targeting Asparagine Metabolism in Well-Differentiated/Dedifferentiated Liposarcoma.

Kyle D Klingbeil, Blake R Wilde, Danielle S Graham

|Sep 28, 2023
IGF2BP3 as a Prognostic Biomarker in Well-Differentiated/Dedifferentiated Liposarcoma.

Kyle D Klingbeil, Jack Pengfei Tang, Danielle S Graham

|Aug 19, 2021
A Randomized Phase II Study of Nivolumab Monotherapy or Nivolumab Combined with Ipilimumab in Patients with Advanced Gastrointestinal Stromal Tumors.

Arun S Singh, J Randolph Hecht, Lee Rosen

|Aug 28, 2020
Chemotherapy and Survival in Patients with Primary High-Grade Extremity and Trunk Soft Tissue Sarcoma.

Danielle S Graham, Ritchell van Dams, Nicholas J Jackson

Pageof 3

Frequent Collaborators

8 joint publications

Tara Russell

7 joint publications

Bartosz Chmielowski

4 joint publications

Danielle S Graham

4 joint publications

Joseph G Crompton